156 related articles for article (PubMed ID: 30451800)
1. Proinsulin Expressing Neuroendocrine Tumors of the Pancreas: An Underrecognized Entity.
Celli R; Tang LH; Cai G; Freedman-Weiss M; Colunga M; Salem RR; Majumdar S; Jain D
Pancreas; 2019 Jan; 48(1):55-59. PubMed ID: 30451800
[TBL] [Abstract][Full Text] [Related]
2. A Systematic Review of Proinsulin-Secreting Pancreatic Neuroendocrine Tumors.
Murtha TD; Lupsa BC; Majumdar S; Jain D; Salem RR
J Gastrointest Surg; 2017 Aug; 21(8):1335-1341. PubMed ID: 28510792
[TBL] [Abstract][Full Text] [Related]
3. Chromogranin A is a reliable serum diagnostic biomarker for pancreatic neuroendocrine tumors but not for insulinomas.
Qiao XW; Qiu L; Chen YJ; Meng CT; Sun Z; Bai CM; Zhao DC; Zhang TP; Zhao YP; Song YL; Wang YH; Chen J; Lu CM
BMC Endocr Disord; 2014 Aug; 14():64. PubMed ID: 25099181
[TBL] [Abstract][Full Text] [Related]
4. [Pancreatic proinsulinoma].
Kriger AG; Berelavichus SV; Gorin DS; Panteleev VI; Demidova VS; Davydenko PI; Varava AB; Kaldarov AR
Khirurgiia (Mosk); 2021; (3):5-10. PubMed ID: 33710820
[TBL] [Abstract][Full Text] [Related]
5. Molecular alterations in sporadic pancreatic neuroendocrine microadenomas.
Hadano A; Hirabayashi K; Yamada M; Kawanishi A; Takanashi Y; Kawaguchi Y; Nakagohri T; Nakamura N; Mine T
Pancreatology; 2016; 16(3):411-5. PubMed ID: 26905832
[TBL] [Abstract][Full Text] [Related]
6. Intra-arterial calcium stimulation test for detection of insulinomas: detection rate, responses of pancreatic peptides, and its relationship to differentiation of tumor cells.
Won JG; Tseng HS; Yang AH; Tang KT; Jap TS; Kwok CF; Lee CH; Lin HD
Metabolism; 2003 Oct; 52(10):1320-9. PubMed ID: 14564685
[TBL] [Abstract][Full Text] [Related]
7. Insulinoma-associated protein 1 (INSM1) is a robust marker for identifying and grading pancreatic neuroendocrine tumors.
Kim D; Viswanathan K; Goyal A; Rao R
Cancer Cytopathol; 2020 Apr; 128(4):269-277. PubMed ID: 31977134
[TBL] [Abstract][Full Text] [Related]
8. Beta-cell adenomas without hyperinsulinemia with use of highly specific insulin radioimmunoassays: case report and review of literature.
Gómez-Pérez FJ; Cuevas-Ramos D; Valdés PA; Aguilar-Salinas CA; Mehta R; Rull JA
Endocr Pract; 2010; 16(4):660-3. PubMed ID: 20439243
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of an "amended" insulin-glucose ratio for the biochemical diagnosis of insulinomas.
Nauck MA; Meier JJ
Ann Intern Med; 2012 Dec; 157(11):767-75. PubMed ID: 23208166
[TBL] [Abstract][Full Text] [Related]
10. Multiple proinsulin-secreting tumors of the pancreas treated by laparoscopic distal pancreatectomy and splenectomy.
Clark G; Sadur C; Puligandla B
World J Surg; 2009 Mar; 33(3):397-9. PubMed ID: 18949512
[TBL] [Abstract][Full Text] [Related]
11. Progesteron receptor expression in insulin producing cells of neuroendocrine neoplasms.
Tachibana T; Kasajima A; Aoki T; Tabata T; McNamara K; Yazdani S; Satoko S; Fujishima F; Motoi F; Unno M; Sasano H
J Steroid Biochem Mol Biol; 2020 Jul; 201():105694. PubMed ID: 32437964
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and minimally invasive resection of an insulinoma: report of an unusual case and review of the literature.
Gutelius BJ; Korytkowski MT; Carty SE; Hamad GG
Am Surg; 2007 May; 73(5):520-4. PubMed ID: 17521012
[TBL] [Abstract][Full Text] [Related]
13. Hypoglycemic Syndrome without Hyperinsulinemia. A Diagnostic Challenge.
Pérez-Pevida B; Idoate MÁ; Fernández-Landázuri S; Varo N; Escalada J
Endocr Pathol; 2016 Mar; 27(1):50-4. PubMed ID: 26801953
[TBL] [Abstract][Full Text] [Related]
14. The predictive value of mean platelet volume in differential diagnosis of non-functional pancreatic neuroendocrine tumors from pancreatic adenocarcinomas.
Karaman K; Bostanci EB; Aksoy E; Kurt M; Celep B; Ulas M; Dalgic T; Surmelioglu A; Hayran M; Akoglu M
Eur J Intern Med; 2011 Dec; 22(6):e95-8. PubMed ID: 22075321
[TBL] [Abstract][Full Text] [Related]
15. Proinsulin-secreting neuroendocrine tumor of the pancreas.
Piovesan A; Pia A; Visconti G; Terzolo M; Leone A; Magro G; Cesario F; Borretta G
J Endocrinol Invest; 2003 Aug; 26(8):758-61. PubMed ID: 14669832
[TBL] [Abstract][Full Text] [Related]
16. Tumor and serum levels of proinsulin and insulin in insulinoma patients.
Tasaka Y; Nakaya F; Matsumoto H; Odagiri R; Ohgawara H; Omori Y
Endocr J; 1993 Apr; 40(2):245-8. PubMed ID: 7951510
[TBL] [Abstract][Full Text] [Related]
17. Hypoglycemia in response to glucose and glucagon in insulinoma patients with a negative prolonged fast: functional and morphological properties.
Wiesli P; Schmid C; Perren A; Pfammatter T; Spinas GA; Keller U
J Endocrinol Invest; 2004 Oct; 27(9):832-8. PubMed ID: 15648547
[TBL] [Abstract][Full Text] [Related]
18. PTCH 1 staining of pancreatic neuroendocrine tumor (PNET) samples from patients with and without multiple endocrine neoplasia (MEN-1) syndrome reveals a potential therapeutic target.
Gurung B; Hua X; Runske M; Bennett B; LiVolsi V; Roses R; Fraker DA; Metz DC
Cancer Biol Ther; 2015; 16(2):219-24. PubMed ID: 25482929
[TBL] [Abstract][Full Text] [Related]
19. [Insulinoma with hyperproinsulinemia: a two cases report].
Gury H; Rio F; Neamtu D; Boivin S
Ann Endocrinol (Paris); 2002 Jun; 63(3):240-2. PubMed ID: 12193882
[TBL] [Abstract][Full Text] [Related]
20. Insulin levels measured with an insulin-specific assay in patients with fasting hypoglycaemia related to endogenous hyperinsulinism.
Vezzosi D; Bennet A; Fauvel J; Boulanger C; Tazi O; Louvet JP; Caron P
Eur J Endocrinol; 2003 Nov; 149(5):413-9. PubMed ID: 14585087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
